When the Wrong Patient Wants Opioids

Video

When a patient comes strolling into your office at 4:30 p.m. on a Friday wanting an opioid prescription, that could be a red flag, Suresh Reddy, MD, professor of palliative care at the University of Texas MD Anderson Cancer Center told MD Magazine.

When a patient comes strolling into your office at 4:30 p.m. on a Friday wanting an opioid prescription, that could be a red flag, Suresh Reddy, MD, professor of palliative care at the University of Texas MD Anderson Cancer Center told MD Magazine.

Reddy gave a presentation at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California entitled, “Pain Management in 2017.” Physicians are well aware of the opioid epidemic and most have probably dealt with difficult patients, meaning that they have no interest in trying alternative forms of pain relief and just want a prescription.

“You have to be careful,” Reddy started off the conversation, “it can be daunting in a solo practice, so I advocate you have a team.”

Reddy acknowledges that patients with opioid misuse have a disease, but physicians need to take the reins and set rules. This could mean frequent visits or urine drug screens, but physicians need to take the time to manage their patients’ pain and opioid use.

>>> More Coverage from ACP 2017

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.